News & Resources

Beyond the Conference: How to Reenergize Your Message Post-congress

After some of the important 2019 conferences have come to an end, it’s time to reevaluate your product’s or corporate messaging and decide how it fits within the trending insights and newsworthy industry knowledge you gathered from your experiences.

Learning about the appropriate evolution of your marketing message post-congress is key to maintaining its buzz—from the use of dedicated conference hashtags to employing conference insights. As your marketing strategy matures, your message should develop awareness tactics and integrate validation studies that back it up.

Relate Your Message to Conference Insights
Right after the conference, review and study conference materials and any notes you might have taken, look to conference coverage reports for highlighted takeaways and breakout insights, and tweak your message to reflect what you learned. This is still an ideal time to latch onto those dedicated hashtags and continue the conversation past the conference.

Conferences are all about big marketing and networking opportunities, but when all is said and done, if you can make a connection between your product and the enduring conference buzz, you’ll discover an audience that is thirsty for more.

If you can communicate the relevance of your product in the context of important industry discoveries and apply it to a real-world setting, you’ll find your message generating some well-earned attention.

Mix Up Content Supporting Your Message
When updating your message according to industry trends and the information you gathered at the conference, be mindful of your content. Try mixing up different types of content that support your message. Include original content, links to news articles and websites, or user-generated content to lend an authentic voice and personal narrative to your product messaging.

Big industry conferences do a good job of balancing social and informational aspects for a pretty intense experience, and post-conference messaging and content should follow suit. Offer content that emphasizes both a social and a professional or educational tone, and be sure to keep it current.

Most importantly, communicate quality to build trust in your brand. Use consistent elements, be it color constructs, graphics, or a tagline, and make sure any sources you use are reputable and relate to your messaging goals.

Target Audience
To be selective about who receives your message, make sure you understand your audience and use mapping tools and targeting techniques to get the right message out to the right people. This approach further allows you to personalize content and channels of communication.

A new goal for pharma communications companies is to establish their own communities of interest. In this sense, a curated audience is more likely to contribute to the conversation and encourage group involvement. This is a key strategy for increasing collective knowledge for future and ongoing messaging purposes.

Attach Your Message to Awareness Campaigns
After you’ve garnered attention for relevant content bathed in post-conference insight, make your long-term message about awareness. In other words, now that you’ve increased communications and found your audience, create opportunities to educate about your product.

At this stage, your messaging goals should go beyond promoting your product or capturing the right audience; an interactive campaign that raises awareness through meaningful, educational content is the best strategy. This is especially effective for newly launched products or products that have new uses or indications.

Educating your audience about the benefits of your product has another advantage: establishing brand loyalty. This extends to educating your audience about the medical condition your product benefits, creating comfort as well as value around your product.

Evolve Your Message to Validate Product Efficacy
After launching your product—and after you’ve achieved awareness—use messaging to validate your product efficacy. This is the last stage in the evolution of your post-conference marketing message, and it’s necessary for maximizing the acceptance of your product in the market space.

Validation involves the collection, analysis, and presentation of data that enlighten the audience to the product’s performance potential. In an increasingly skeptical landscape, this is practically a requirement for pharma companies.

A validation study provides powerful marketing fodder, but it can also inform pre-launch activities by binding your audience together through a shared interest: seeing your product through the pipeline. Validation is a process that continues through product launch but should enter your marketing strategy as your message becomes increasingly specific.

With these tips, you’ll be able to reenergize your message post-congress and keep your products relevant.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.